|
IDENTIFICATION AND USE OF miRNAs FOR DIFFERENTIATING MYELOGENOUS LEUKAEMIA CELLS |
|
Principal Investigator: O. VOINNET
|
|
The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukaemia.
To read more, please register or connect in the right pannel... |
